Yüklüyor......
Phase 0 - Microdosing strategy in clinical trials
Drug development is an activity that is long, complex and expensive. In 2004, attrition in the drug development paradigm prompted the US Food and Drug Administration (FDA) to introduce its ‘Critical Path’ document, which highlighted the serious discordance between major scientific advances and limit...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medknow Publications
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3025138/ https://ncbi.nlm.nih.gov/pubmed/21279177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.45147 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|